A retrospective assessment comparing pharmacist-managed anticoagulation clinic with physician management using international normalized ratio stability

Journal of Thrombosis and Thrombolysis

Volumn 32, Issue 4, 2011, Pages 426-430

  Garton, Lauren ^b   Crosby, Joseph F ^a  

^a Armstrong State University   (United States)

^b NONE

Author keywords

Anticoagulation; Outpatient clinic; Pharmacist clinic; Pharmacist managed

Indexed keywords

WARFARIN;

AGED; ANTICOAGULANT THERAPY; ARTICLE; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DOCTOR PATIENT RELATION; FEMALE; HUMAN; INTERNATIONAL NORMALIZED RATIO; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PATIENT SAFETY; PHARMACIST ATTITUDE; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT PLANNING;

AMBULATORY CARE FACILITIES; ANTICOAGULANTS; DATA COLLECTION; HUMANS; INTERNATIONAL NORMALIZED RATIO; PHARMACISTS; PHYSICIANS; PRACTICE MANAGEMENT; RETROSPECTIVE STUDIES;

EID: 82955163164     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-011-0612-7     Document Type: Article

References (12)

1. Francis C (2008) New issues in oral anticoagulants. Hematology2008(1): 259-265
2. Baetz B, Spinler S (2008) Dabigatran etexilate: an oral directthrombin inhibitor for prophylaxis and treatment of thromboem bolicdiseases. Pharmacotherapy 80(11):1354-1373
3. Garcia D, Libby E, Crowther M (2010) The new oral anticoagulants. Blood 115(1):15-120
4. Bounameaux H (2009) The novel anticoagulants: entering a newera. Swiss Med Wkly 139(5-6):60-64
5. Bellamy L, Rosencher N, Eriksson BI (2009) Adherence to a neworal anticoagulant treatment prescription: dabigatran etexilate. Patient Prefer Adherence 3:173-177
6. Horton J, Bushwick B (1999) Warfarin therapy: evolvingstrategies in anticoagulation. Am Fam Physician 59(3):635-646
7. Chiquette E, Amato M, Bussey H (1998) Comparison of ananticoagulation clinic with usual medical care; anticoagulationcontrol, patient outcomes, and health care costs. Arch Intern Med158:1641-1647 (Pubitemid 28371187)
8. Preventing errors relating to commonly used anticoagulants. TheJoint Commission; Sentinel Event Alert; c2008. http://www. jointcommission. org/SentinelEvents/SentinelEventAlert/sea-41. htm. Accessed 21 Jan 2010
9. Lassen M, Laux V (2008) Emergence of new oral antithrombotics:a critical appraisal of their clinical potential. Vasc HealthRisk Manag 4(6):1373-1386
10. Gandhi T, Shojania K, Bates D. Chapter 9. Protocols for high-riskdrugs: reducing adverse drug events related to anticoagulants. AHRQ. http://archive.ahrq.gov/clinic/ptsafety/chap9.htm. Accessed1 Jan 2010
11. George J, Popma J (2009) Reduced reimbursement for cardiovascularservices by the centers for medicare and medicaid services. JACC: Cardiovasc Interv 2(9):894-896
12. Chamberlain M, Sageser N, Ruiz D (2001) Comparison of anticoagulationclinic patient outcomes with outcomes from traditionalcare in a family medicine clinic. JABFP 14(1):16-21 (Pubitemid 33605759)